ABMC Posts Net Sales Of $2.2 Million For Q1 2009

ABMC chief executive officer, Stan Cipkowski, stated, “Our story hasn’t changed much since March when we reported results for our 2008 fiscal year. We continue to experience decreased sales in our core markets. Workplace drug testing continues to be affected by historically high unemployment rates in the United States, and government sales continue to be affected by budget cuts and price pressures from foreign manufacturers.”

Cipkowski added, “We are encouraged by recent news that employers cut fewer jobs in April, which could indicate that the worst of the recession has passed; we hope this means we will start to see sales in the workplace market begin to rebound sometime in 2009. We have also been making progress in garnering new accounts to make up for sales declines with our current customers. At the same time, we have started selling a new version of our Rapid TOX Cup product in the government market with some early success stories. It is our hope that we can stabilize sales in our core markets while keeping costs in line with sales levels; if we can do that, we can get through this economic crisis.”